
Frontiers of Biomedical Science
Wednesday, October 19, 2005 - Thursday, October 20, 2005
Presented By
On October 19-20, 2005 eminent scientists from Europe, the US and China met to explore the most critical issues and research on the forefront of four cutting-edge disciplines:
- Chemical Biology
- Infectious Disease
- Genomic Medicine
- Neuroscience
Plenary lectures were combined with four concurrent interactive workshops attended by elite young Chinese scientists and international representatives from academia and industry.
Speakers
- Soren F. Andersen (Wyeth Research)
- Emile-Etienne Baulieu (Cedex)
- Jan Carlstedt-Duke (Karolinska Institute)
- Zhu Chen (Chinese Academy of Sciences)
- Virginia Cornish (Columbia University)
- Peter B. Corr (Pfizer, Inc.)
- Lin He (Shanghai Jiao-Tong University)
- Hua-Liang Jiang (Shanghai Institute of Materia Medica, CAS)
- Keith Jones (Affymetrix, Inc.)
- Xiang-Yun Kong (Health Science Center, SIBS, CAS)
- Bruce Lahn (Howard Hughes Medical Institute)
- Chi-Ming Lee (AstraZeneca Pharmaceuticals LP)
- Marc Lipsitch (Harvard School of Public Health)
- Da-Wei Ma (Shanghai Institute of Organic Chemistry, CAS)
- Jeremy Paul (New York Academy of Sciences)
- David Perlin (Public Health Research Institute)
- John Reid (AstraZeneca Pharmaceuticals LP)
- Glenn Rice (Bridge Pharmaceuticals, Inc.)
- Ellis Rubinstein (New York Academy of Sciences)
- Joanna Rubinstein (Columbia University Medical School)
- Bin Sun (Institute of Biochemistry and Cell Biology, SIBS, CAS)
- Gregory Verdine (Harvard University)
- Yi-Zheng Wang (Institute of Neuroscience, SIBS, CAS)
- Jiarui Wu (Shanghai Institutes for Biological Science, CA)
- Zheng-Hong Yuan (Fu-Dan University)
- Xu Zhang (Institute of Neuroscience, SIBS, CA)
The meeting has been made possible with funding from
- Alexandria Real Estate Equities
- AstraZeneca
- Pfizer
- Affymetrix
- Wyeth
- Lundbeck
- Bridge Pharmaceuticals
- CMEA Ventures
- Nature Publishing Group
- The Karolinska Institute
- PricewaterhouseCoopers.